UPDATE 1-Fund manager Ackman calls Valeant 'very valuable asset'

NEW YORK, March 8 (Reuters) - Billionaire investor Bill Ackman on Tuesday called embattled drug company Valeant Pharmaceuticals a "very valuable asset" but forecast that if the company's situation...